El-Deeb, O.S.; Elesawy, R.O.; Eltokhy, A.K.; Al-Shenawy, H.A.; Ghanem, H.B.; Rizk, F.H.; Barhoma, R.A.; Shalaby, R.H.; Abdelsattar, A.M.; Mashal, S.S.;
et al. Moderating Gut Microbiome/Mitochondrial Axis in Oxazolone Induced Ulcerative Colitis: The Evolving Role of β-Glucan and/or, Aldose Reductase Inhibitor, Fidarestat. Int. J. Mol. Sci. 2023, 24, 2711.
https://doi.org/10.3390/ijms24032711
AMA Style
El-Deeb OS, Elesawy RO, Eltokhy AK, Al-Shenawy HA, Ghanem HB, Rizk FH, Barhoma RA, Shalaby RH, Abdelsattar AM, Mashal SS,
et al. Moderating Gut Microbiome/Mitochondrial Axis in Oxazolone Induced Ulcerative Colitis: The Evolving Role of β-Glucan and/or, Aldose Reductase Inhibitor, Fidarestat. International Journal of Molecular Sciences. 2023; 24(3):2711.
https://doi.org/10.3390/ijms24032711
Chicago/Turabian Style
El-Deeb, Omnia Safwat, Rasha Osama Elesawy, Amira K. Eltokhy, Hanan Alsaeid Al-Shenawy, Heba Bassiony Ghanem, Fatma H. Rizk, Ramez AE Barhoma, Rania H. Shalaby, Amal M. Abdelsattar, Shaimaa S. Mashal,
and et al. 2023. "Moderating Gut Microbiome/Mitochondrial Axis in Oxazolone Induced Ulcerative Colitis: The Evolving Role of β-Glucan and/or, Aldose Reductase Inhibitor, Fidarestat" International Journal of Molecular Sciences 24, no. 3: 2711.
https://doi.org/10.3390/ijms24032711
APA Style
El-Deeb, O. S., Elesawy, R. O., Eltokhy, A. K., Al-Shenawy, H. A., Ghanem, H. B., Rizk, F. H., Barhoma, R. A., Shalaby, R. H., Abdelsattar, A. M., Mashal, S. S., Eshra, K. A., El-Sharaby, R. M., Ali, D. A., & Ibrahim, R. R.
(2023). Moderating Gut Microbiome/Mitochondrial Axis in Oxazolone Induced Ulcerative Colitis: The Evolving Role of β-Glucan and/or, Aldose Reductase Inhibitor, Fidarestat. International Journal of Molecular Sciences, 24(3), 2711.
https://doi.org/10.3390/ijms24032711